Abstract:Background Radiotherapy is one of the most important therapeutic strategies for treating cancer. For decades, studies concerning the outcomes of radiotherapy mainly focused on the biological effects of radiation on tumor cells. Recently, we have increasingly recognized that the complex cellular interactions within the tumor microenvironment (TME) are closely related to treatment outcomes. Main content As a critical component of the TME, fibroblasts participate in all stages of cancer progression. Fibroblasts are able to tolerate harsh extracellular environments, which are usually fatal to all other cells. They play pivotal roles in determining the treatment response to chemoradiotherapy. Radiotherapy activates the TME networks by inducing cycling hypoxia, modulating immune reaction, and promoting vascular regeneration, inflammation and fibrosis. While a number of studies claim that radiotherapy affects fibroblasts negatively through growth arrest and cell senescence, others argue that exposure to radiation can induce an activated phenotype in fibroblasts. These cells take an active part in constructing the tumor microenvironment by secreting cytokines and degradative enzymes. Current strategies that aim to inhibit activated fibroblasts mainly focus on four aspects: elimination, normalization, paracrine signaling blockade and extracellular matrix inhibition. This review will describe the direct cellular effects of radiotherapy on fibroblasts and the underlying genetic changes. We will also discuss the impact of fibroblasts on cancer cells during radiotherapy and the potential value of targeting fibroblasts to enhance the clinical outcome of radiotherapy. Conclusion This review provides good preliminary data to elucidate the biological roles of CAFs in radiotherapy and the clinical value of targeting CAFs as a supplementary treatment to conventional radiotherapy. Further studies to validate this strategy in more physiological models may be required before clinical trial.

Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy

Interaction of Cancer-Associated Fibroblasts and Tumor Cells in Carcinogenesis

Cancer‐associated Fibroblasts in Breast Cancer: Challenges and Opportunities

[Progress on Cancer Associated Fibroblasts in Tumor Immunoregulation].

Cancer Associated Fibroblasts: an Essential Role in the Tumor Microenvironment

Fibrosis and cancer: A strained relationship

Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets

The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment

Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers

Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities

Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth

Fibroblasts in the Tumor Microenvironment: Shield or Spear?

Cancer-associated fibroblasts: from basic science to anticancer therapy

Modulation of the antitumor immune response by cancer-associated fibroblasts: mechanisms and targeting strategies to hamper their immunosuppressive functions

Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment

DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS.

Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer

Advances in the Study of Carcinoma-Associated Fibroblasts

Cancer-associated fibroblasts: The chief architect in the tumor microenvironment